Skip to content

Effects of Resistance Training on Physical Activity in Daily Life and Functional Capacity in Hemodialysis Patients

Effects of Resistance Training on Physical Activity in Daily Life, Muscle Function and Functional Capacity in Patients With End Stage Renal Disease on Hemodialysis: a Randomised Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02651025
Enrollment
29
Registered
2016-01-08
Start date
2016-01-31
Completion date
2017-03-31
Last updated
2016-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Insufficiency, Chronic

Brief summary

The purpose of this study is to determine whether a supervised resistance exercise training during hemodialysis is effective to increase physical activity in daily life in patients with end stage renal disease.

Detailed description

The patients will be randomized into two groups: intervention and control groups. Patients in the intervention group will receive a supervised resistance exercise training, during hemodialysis, three times/week for 12 weeks, and patients allocate to the control group will received a passive stretching program during the same timeframe.

Interventions

During the first week of training will be conducted two sets of 10 repetitions, and from the second week of training until the twelfth will be performed three sets of 10 repetitions. The work rate will set to the tolerance of each patient as established by his/her inability to maintain Borg ratings for dyspnea and effort (10-point category-ratio Borg scale) scores between 4 and 6.

Sponsors

Federal University of Juiz de Fora
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with end stage renal disease on hemodialysis for at least three months * Sedentary for at least six months

Exclusion criteria

* Presence of physical limitations that prevent the implementation of physical tests * Presence of severe comorbidity and unstable (unstable angina, decompensated heart failure, myocardial infarction history of the past six months, cardiac arrhythmias, uncontrolled hypertension with systolic blood pressure ≥ 200 mmHg and / or diastolic blood pressure ≥ 120 mmHg, diabetes decompensated, severe lung disease, acute systemic infection as well as neurological disorders, musculoskeletal and osteoarticular or other disabling conditions according to the clinical judgment) * Hospitalization in the three months prior to study entry

Design outcomes

Primary

MeasureTime frameDescription
Physical Activity in Daily Life12 weeksThe physical activity in daily life will be estimated as the mean number of steps using a triaxial accelerometer.

Secondary

MeasureTime frameDescription
Functional capacity12 weeksThe functional capacity will be assessed by six-minute walking test.
Quality of life12 weeksThe quality of life will be assessed by the 36-Item Short Form Health Survey (SF36).
Muscle function12 weeksThe muscle function will be assessed by electromyography.
Muscle strength12 weeksThe measurement of maximal voluntary strength of handgrip will be assessed by hydraulic model of dynamometer.
Depression and anxiety12 weeksDepression and anxiety will be assessed by the Hospital Anxiety and Depression Scale.

Countries

Brazil

Contacts

Primary ContactFelipe M Valle
felipemartins.valle@gmail.com5532988579609
Backup ContactMaycon Reboredo, DSc
mayconreboredo@yahoo.com.br5532988365529

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026